Ceres
(NASDAQ: CERE)
-0.04
-1.05%
Ceres, a micro-cap growth company in the health care sector, is expected to significantly underperform the market over the next six months with very high risk.
10 is the best possible rating.
Previous day's closing price for CERE was significantly above its 50-day moving average. Very positive
ConThe price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Negative for a small company like CERE
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
The price-to-earnings multiple is a negative number. No effect
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
Earnings growth information is unavailable or inconsistent.
One or more analysts has modestly decreased quarterly earnings estimates for CERE. Negative
Insider trading information is unavailable or inconsistent.
Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like CERE
The price-to-earnings multiple is a negative number. No effect
The price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Negative for a small company like CERE
The ratio of CERE's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.
The StockScouter measure of relative price change and consistency is very low. Very negative
Previous day's closing price for CERE was significantly above its 50-day moving average. Very positive
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 6/19/2013 3:05 PM ET
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
